Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib.

Oztan, A

Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 09 2017 - 84-87 p. digital

Publication Type: Case Reports; Journal Article

1872-8332

10.1016/j.lungcan.2017.07.002 doi


Acrylamides
Adenocarcinoma--drug therapy
Adenocarcinoma of Lung
Aged
Alleles
Amino Acid Substitution
Aniline Compounds
Antineoplastic Agents--pharmacology
Disease Progression
Drug Resistance, Neoplasm--genetics
ErbB Receptors--genetics
Exons
Fatal Outcome
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation
Neoplasm Staging
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Tomography, X-Ray Computed
Treatment Outcome